Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia-1

Neurology

Volumn 47, Issue 1, 1996, Pages 249-253

  Vig, P J S ^a   Fratkin, J D ^a   Desaiah, D ^a   Currier, R D ^a   Subramony, S H ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; PARVALBUMIN;

ARTICLE; ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; CALCIUM HOMEOSTASIS; CELL SURVIVAL; CHROMOSOME 6; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PURKINJE CELL; SPINOCEREBELLAR DEGENERATION; STELLATE CELL;

EID: 0030056030     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.249     Document Type: Article

References (31)

1. Orr HT, Chung M-yi, Bonfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
2. Bebin EM, Bebin J, Currier RD, Smith EE, Perry TL. Morphometric studies in dominant olivopontocerebellar atrophy. Arch Neurol 1990;47:188-192.
3. Koeppen AH, Turok DI. The cerebellar cortex and the dendate nucleus in hereditary ataxia. In: Plaitakis A, ed. Cerebellar degenerations: clinical neurobiology. Boston: Kluwer Academic Publishers, 1992:205-236.
4. Subramony SH, Smith EE, Currier RD, et al. Purkinje cell loss before clinical onset in dominant cerebellar ataxia [abstract]. Neurology 1986(Suppl);36:302.
5. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr H, Zoghbi H. Expression analysis of the ataxin-1 protein in tissue from normal and spinocerebellar ataxia type 1 individuals. Nat Genet 1995;10:94-98.
6. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992;15:303-308.
7. 2+ -binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15:259-264.
8. Cheema IR, Western L, Wadley AM. Effect of parvalbumin and S-100 protein on protein synthesis in rabbit reticulocyte lysate. Cytobios 1991;68:77-83.
9. Plogmann D, Celio MR. Intracellular concentration of parvalbumin in nerve cells. Brain Res 1993;600:273-279.
10. Sloviter RS, Sollas AL, Barbaro NM, Laxer KD. Calcium binding proteins calbindin (28k) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J Comp Neurol 1991;308:381-396.
11. Tortosa A, Ferrer I. Parvalbumin immunoreactivity in hippocampus of the gerbil after transient forebrain ischemia: a qualitative and quantitative sequential study. Neuroscience 1993;55:33-43.
12. Nishiyama E, Ohwada J, Iwamoto N, Arai H. Selective loss of calbindin D28K-immunoreactive neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study. Neurosci Lett 1993;163:223-226.
13. Ferrer I, Casas R, Rivera R. Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease. Ann Neurol 1993;34:864-866.
14. Ishikawa K, Mizusawa H, Fujita T. Calbindin-D 28k immunoreactivity in the cerebellum of spinocerebellar degeneration. J Neurol Sci 1995;129:179-185.
15. Desaiah D, Subramony SH, Vig PJS, Currier RD. Phosphoinositide second messenger system in human OPCA and the mouse model. In: Harding AE, Deufel T, eds. Advances of neurology. Vol. 61. New York: Raven Press, 1993:167-173.
16. Vig PJS, Subramony SH, Currier RD, Desaiah D. Inositol 1,4,5-trisphosphate metabolism in the cerebella of lurcher mutant mice and patients with olivopontocerebellar atrophy. J Neurol Sci 1992;110:139-143.
17. Vig PJS, Desaiah D, Subramony SH, Joshi P, Fratkin JD, Currier RD. Decreased insulin-like growth factor I-mediated protein tyrosine phosphorylation in human olivopontocerebellar atrophy and lurcher mutant mouse. J Neurol Sci 1994;124: 38-44.
18. Ranum L, Chung M, Banfi S, et al. Molecular and clinical correlations in spinocerebellar ataxia type 1: evidence for familial effects on the age of onset. Am J Hum Genet 1994;55: 244-252.
19. Satoh J, Tabira T, Sano M, Nakayama H, Tateishi J. Parvalbumin immunoreactive neurons in human central nervous system are decreased in Alzheimer's disease. Acta Neuropathol (Berl) 1991;81:388-395.
20. Mito DR, Becker L. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome. Exp Neurol 1993;120:170-176.
21. 2+-binding proteins in normal and tumor cells: a topical review. Cell Calcium 1987;8:1-41.
22. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers. Their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994;91:5355-5358.
23. Ichimiya YE, Mountjoy CQ, Lawson DEM, Heizmann CW. Loss of calbindin-28K immunoreactive neurons from the cortex in Alzheimer-type dementia. Brain Res 1989;475:156-159.
24. Hof PR, Cox K, Young WG, Celio MR, Rogers J, Morrison JH. Parvalbumin immunoreactive neurons are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 1991;50:451-462.
25. Ferrer I, Soriano E, Tunon T, Fonseca M, Guionnet N. Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J Neurol Sci 1991;106:135-141.
26. Iacopino AM, Christakos S. Specific reduction of calcium binding protein (28-kildalton Calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 1990;87:4078-4082.
27. Elliott J, Snider W. Differential gene expression in ALS-sensitive and ALS-resistant motor neurons [abstract]. Neurology 1995;45(suppl 4):305.
28. Kamphuis W, Huisman E, Wadman WJ, et al. Kindling induced changes in parvalbumin immunoreactivity in rat hippocampus and its relation to long-term decrease in GABA-immunoreactivity. Brain Res 1989;479:23-34.
29. deViragh PA, Haglid KG, Belio MR. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci USA 1989;86:3887-3890.
30. Brewer JM, Wunderlich JK, Kim D-H, Carr MY, Beach GG, Ragland WL. Avian thymic hormone (AVH) is a parvalbumin. Biochem Biophys Res Commun 1989;160:1155-1161.
31. Wuenschell CW, Messer A, Tovin AJ. Lurcher Purkinje cells express glutamic acid decarboxylase and calbindin mRNAs. J Neurosci Res 1990;27:65-70.